BTOG 2017 Programme

BTOG 2017 Programme Continuing Professional Development – BTOG 2017 is accredited by The Royal College of Pathologists for 13 CPD credits (Weds 3, Thurs 6, Fri 4) The Royal College of Surgeons of England for up to 18 CPD points (max 6 per day) RCSI Faculty of Radiologists for 13.75 CPD credits (Weds 3, Thurs 6, Fri 4.75) - Accepted by all Irish Postgraduate Medical Training Bodies Continuing Professional Development – accreditation also applied for from The Federation of the Royal Colleges of Physicians of the United Kingdom

Wednesday 25th January 2017 10:30 Registration Opens & Refreshments The BTOG Desk is available for registration/information throughout BTOG 2017.

Ground Floor Conference Foyer

11:00 – 14:30 BTOG Parallel Symposia (4) BTOG Translational Research Symposium Session 1 Chairs: 11:00 11:30 12:00

Optimal Selection for Immunotherapy Ken O’Byrne (AU) and Stephen Finn (IE) 20 minutes + 10 minutes discussion per speaker Are PDL1 tests inter-changeable? Genomic correlates for immunotherapy selection Patient selection for 1st line immunotherapy: clinical factors

12:30 – 13:00 Lunch, Exhibition and Posters

Session 2 Chairs: 13:00 13:15 13:35 13:50 14:10 14:30

Beyond Immune Checkpoint Inhibition Rolf Stahel (EU) and Keith Kerr (UK) Can microbiome predict immunotherapy benefit? Are there meaningful differences between checkpoint inhibitors? Will CAR-Ts deliver for thoracic malignancies? Immunotherapy drug development: what’s next? Discussion Close

14:30 – 15:00 Refreshments, Exhibition and Posters

Herbert Room

Fred Hirsch (US) Jurgen Wolf (EU) Benjamin Besse (EU) Ground Floor Conference Foyer

Bertrand Routy (EU) Frances Shepherd (CA) Sophie Papa (UK) David Carbone (US)


BTOG 2017 Programme FINAL

Wednesday 25th January 2017 BTOG Radiotherapy Training Symposium Chairs: Panel: Session 1 11:00 11:15 11:30 11:45 12:00

Corinne Faivre-Finn (UK) and Fiona McDonald (UK) All speakers Radiotherapy-induced Cardiac Toxicity Why should we be concerned about cardiac toxicity? Data on cardiac toxicity from IDEAL Data mining data on cardiac toxicity from Manchester Pilot work on cardiac imaging before/after RT from Glasgow Panel and audience discussion

12:30 – 13:00 Lunch, Exhibition and Posters Session 2 13:00

13:10 13:30 14:00 14:30

BTOG Respiratory Medicine Symposium

11:00 11:30 12:00

13:00 13:30 14:00 14:30


Ground Floor Conference Foyer Pembroke Room

Mesothelioma – Developing Patient-Centred Care in 2017 Nick Maskell (UK) and Malcolm Lawson (UK) 20 minutes + 10 minutes discussion per speaker How long have I got, doc? Smarter individual prognosis Mark Slade (UK) Patients supporting patients – the role of the support group Liz Darlison (UK) Tailored systemic treatment in 2017 James Spicer (UK)

12:30 – 13:00 Lunch, Exhibition and Posters Session 2 Chair:

Marianne Aznar (UK) Sindu Vivekanandan (UK) Alan McWilliam (UK) Kirsty MacLennan (UK)

SABR for Oligometastatic Disease Introduction and key questions Fiona McDonald (UK) Debate: ‘The UK will fall behind the rest of the world if SABR is not introduced routinely for oligometastatic disease’ For the motion Nick van As (UK) Against the motion Daniel Gomez (US) Panel and audience discussion - chairs/speakers and David Landau (UK) Close


Session 1: Chair:

Meeting Room 1 & 2 1st Floor


Avoiding Emergency Presentations of Lung Cancer in 2017 David Baldwin (UK) and Helen Powell (UK) 20 minutes + 10 minutes discussion per speaker The scope of the problem – what the NLCA can tell us Ian Woolhouse (UK) Picking up symptomatic patients earlier – what the chest physician can do Matthew Callister (UK) Maximising ambulatory care of patients with thoracic malignancy David Feller-Kopman (US) Close


Ground Floor Conference Foyer BTOG 2017 Programme FINAL

Wednesday 25th January 2017 BTOG Radiology Symposium Session 1 Chair: 11:00 11:30 12:00

Anthony Edey (UK) 20 minutes + 10 minutes discussion per speaker TNM 8th edition – Implications for the CT report CT biopsy and re-biopsy – tips and tricks Tumour response in lung cancer: Recist 1.1and beyond

Meeting Room 6, 1st Floor

Carol Ridge (IE) Anand Devaraj (UK) Charlie Sayer (UK)

12:30 – 13:00 Lunch, Exhibition and Posters Session 2 Chair: 13:00 13:30 14:00 14:30


Anand Devaraj (UK) 20 minutes + 10 minutes discussion per speaker Setting up a lung nodule service - the King’s experience

Sujal Desai (UK)/ Georgia Hardavella (UK) PET/CT and MRI in evaluating anterior mediastinal masses Rachna Madan (US) Indolent/over-diagnosed lung cancers on CT Maurizio Infante (EU) Close



15:00 – 19:45 Sponsored Satellite Symposia 45 minutes per satellite symposium 15:00

Satellite symposium sponsored by AstraZeneca

16:00

Satellite symposium sponsored by Boehringer Ingelheim

17:00

Satellite symposium sponsored by Lilly Oncology

18:00

Satellite symposium sponsored by MSD

19:00

Satellite symposium sponsored by Chugai

19:45

Close

Herbert Room

20:00 – 21:30 BTOG Welcome Reception – Dress code: Smart/Casual Ground Floor Conference Foyer


Thursday 26th January 2017 07:30 Registration Opens & Refreshments The BTOG Desk is available for registration/information throughout BTOG 2017.


08:10 - 08:50 Sponsored Satellite Symposia 08:10

Satellite symposium sponsored by Amgen

Pembroke/Herbert

09:10 – 10:50 Plenary Session 1 Pembroke/Herbert Sanjay Popat (UK) Matthew Hatton (UK) Rolf Stahel (EU) Benjamin Besse (EU)

09:10 09:20 09:30 09:40

Welcome - BTOG NCRI ETOP EORTC

Session 1 Chairs:

Plenary Session John Field (UK), John Edwards (UK) and Denis Talbot (UK) 20 minutes + 10 minutes discussion per speaker Tobacco control in 2017: the Australian story Mike Daube (AU) CT Screening in Europe: now & next steps Harry de Koning (EU)

09:50 10:20



11:20 – 13:00 Plenary Session 2 & 3 Session 2 Chairs: 11:20 11:45 Session 3 Chairs: 12:10 12:12 12:23 12:34 12:45

12:56

Controversies Babu Naidu (UK) and George Santis (UK) 15 minutes + 10 minutes discussion per speaker Pre-surgery functional assessment: mandatory or luxury? EBUS quality assurance: how many cases are enough? Poster Oral Presentations David Dunlop (UK) and Jackie Fenemore (UK) Introduction - 7 minutes + 4 minutes discussion per speaker The effects of a lung cancer triage service on the ‘62-day target’ Diagnostic performance of PET-CT for anterior mediastinal Lesions – the DECiMaL study Adequacy of image-guided rebiopsies for molecular retesting in advanced NSCLC: a single centre experience A retrospective multicentre audit of outcome among patients with Anaplastic Lymphoma Kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with Crizotinib in England Closing comments 13:00 Close

Pembroke/Herbert

Alessandro Brunelli (UK) Richard Booton (UK)

Tim Edwards (UK) Chiara Proli (UK) Nadza Tokaca (UK)

Kent Yip (UK)


Thursday 26th January 2017 13:00 – 14:00 Lunch, Exhibition and Posters



Satellite symposium sponsored by Roche

Pembroke/Herbert

14:00 – 15:30 Plenary Session 4 Pembroke/Herbert Session 4 Chairs: 14:00 14:30 15:00

Multifocal Lung Cancer John Gosney (UK) and Karen Redmond (IE) 20 minutes + 10 minutes discussion per speaker How should multi-focal lung cancer be staged? Primaries or metastases: does pathology matter? Multifocal NSCLC: does surgery have a role?


Ramon Rami-Porta (EU) Alexandra Rice (UK) David Waller (UK) Ground Floor Conference Foyer

16:00 – 18:00 Collaborative Sessions Please see next page.


Thursday 26th January 2017 16:00 – 17:00 Parallel Sessions (2) BTOG/NCRI LOcoRegionalDiagnosis (LORD) Subgroup Update Chairs: 16:00 16:10 16:30 16:50 17:00

Yvonne Summers (UK) and Matthew Hatton (UK) Introduction and overview of current portfolio CONCoRDE (phase 1 RT-DDRi combinations for stage III NSCLC) SABRtooth - Update on recruitment and discussion on further development PEARLS update on UK recruitment Close

BTOG/NCRI Mesothelioma Subgroup Update Chair: 16:00 16:05 16:15 16:25 16:35 16:45 16:50 17:00

Peter Szlosarek (UK) Introduction MARS2 MESOTRAP PROMISE-meso and NEMO CONFIRM and EPIZYME ATOMIC-meso Panel and Q&A Close

Pembroke

Yvonne Summers (UK) Gerry Hanna (UK) and Alastair Greystoke (UK) Kevin Franks (UK) Mary O'Brien (UK)

Herbert

Peter Szlosarek (UK) Eric Lim (UK) Robert Rintoul (UK) Sanjay Popat (UK) Peter Szlosarek (UK) Peter Szlosarek (UK)


17:00 – 18:00 Parallel Sessions (3) Pembroke

BTOG/NCRI Advanced Disease Subgroup Update Chair: 17:00 17:15 17:25 17:35 17:45 18:00

Sanjay Popat (UK) MATRIX/SMP2 N3 CORE SARON HALT Close

Gary Middleton (UK) Sanjay Popat (UK) Merina Ahmed (UK) David Landau (UK) Fiona McDonald (UK)

Herbert

BTOG/NCRI Screening and Early Diagnosis Subgroup Update Chair: 17:00 17:15 17:35 17:55 18:00

Neal Navani (UK) and Robert Rintoul (UK) Introduction and Portfolio update LuCID - Identifying lung cancer with volatile organic compounds CT screening for lung cancer in Yorkshire – what is different? Summary Close

BTOG/NLCFN Nursing Session Chairs: 17:00

Vanessa Beattie (UK) and Angela Tod (UK) Introduction

17:05

Communication of risk of recurrence following lung cancer surgery - update and findings of a study Patient experience of radical surgery – update from the MARS2 sub-study Physical activity following surgery - evidence review and feasibility trial on yoga Discussion Close

17:20 17:35 17:50 18:00

Neal Navani (UK) Robert Rintoul (UK) Matthew Callister (UK) Robert Rintoul (UK)

Meeting Room 1 & 2, 1st Floor Vanessa Beattie and Angela Tod Matthew Johnson (UK) Karen Lord (UK) and Helena Stanley (UK) Katy Clarke (UK)

19:30 – 20:00 BTOG Reception Ground Floor Conference Foyer

20:00 – 23:00 15th Annual BTOG Conference Dinner Dress code: Gents - lounge suit and tie or black tie / Ladies - cocktail wear The conference dinner is ticket only and must be pre-booked and includes presentation of the BTOG Lifetime Achievement Award 2017 and poster awards. Pembroke/Herbert


Friday 27th January 2017 09:00 – 10:45 Plenary Session 5 Pembroke/Herbert

09:00 09:10

Roy Castle Lung Cancer Foundation Grants - David Gilligan (UK) NLCA Report Launch - Ian Woolhouse (UK)

Session 5 Chairs:

BTOG/BTS Collaborative Session – Improving Outcomes Sam Janes (UK), Robert Rintoul (UK) and Ian Woolhouse (UK) 20 minutes + 10 minutes discussion per speaker Lung cancer diagnosis and treatments in the UK Michael Peake (UK) The ambulatory lung biopsy service Sam Hare (UK) 10 minutes + 5 minutes discussion per speaker Does tumour genotyping matter: CRUK SMP2 findings Rowena Sharpe (UK) Does tumour genotyping matter: MATRIX findings Gary Middleton (UK)

09:15 09:45 10:15 10:30



11:15 – 12:45 Plenary Session 6 Session 6 Chairs: 11:15 11:20 11:40 12:00 12:20 12:40

Optimal Supportive Care in 2017 Sam Ahmedzai (UK) and Josie Roberts (UK) 15 minutes + 5 minutes discussion per speaker Introduction Impact of new lung cancer treatments and their toxicities Biological processes underlying symptom clusters in advanced lung cancer New approaches to rehabilitation in lung cancer Round table: What can BTOG do to advance supportive care in lung cancer and mesothelioma? Summary


Pembroke/Herbert

Sam Ahmedzai (UK) Annie Young (UK) Barry Laird (UK) Matthew Maddocks (UK)

Josie Roberts (UK) Ground Floor Conference Foyer


Satellite symposium sponsored by Bristol-Myers Squibb

Pembroke/Herbert

14:00 - 15:30 Plenary Session 7 Session 7 Chairs: 14:00 14:30 15:00

Pembroke/Herbert SCLC: Implications of Recent Studies on Routine Practice Cindy Billingham (UK) and Sinead Cuffe (IE) 20 minutes + 10 minutes discussion per speaker CONVERT trial: what now for radical radiotherapy? Corinne Faivre-Finn (UK) REST trial: clinical implications and next steps? Ben Slotman (EU) PARP, IO, WEE: new systemic therapies for SCLC? Penella Woll (UK)


BTOG 2017 Programme

Recommend Documents